Anchen Pharms Company Profile
✉ Email this page to a colleague
What is the competitive landscape for ANCHEN PHARMS, and what generic and branded alternatives to ANCHEN PHARMS drugs are available?
ANCHEN PHARMS has twenty-seven approved drugs.
There are two tentative approvals on ANCHEN PHARMS drugs.
Drugs and US Patents for Anchen Pharms
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Anchen Pharms | DULOXETINE HYDROCHLORIDE | duloxetine hydrochloride | CAPSULE, DELAYED REL PELLETS;ORAL | 090780-003 | Oct 28, 2015 | DISCN | No | No | ⤷ Try a Trial | ⤷ Try a Trial | |||||
Anchen Pharms | FENOFIBRIC ACID | choline fenofibrate | CAPSULE, DELAYED RELEASE;ORAL | 201573-001 | Jul 18, 2013 | AB | RX | No | No | ⤷ Try a Trial | ⤷ Try a Trial | ||||
Anchen Pharms | LEVETIRACETAM | levetiracetam | TABLET, EXTENDED RELEASE;ORAL | 091360-002 | Oct 4, 2011 | DISCN | No | No | ⤷ Try a Trial | ⤷ Try a Trial | |||||
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
Similar Applicant Names
Here is a list of applicants with similar names.